Category: New England Journal of Medicine
ANN ARBOR, Mich. -- A compelling University of Michigan Health System study debunks assumptions about the role of complications in distinguishing good and bad hospitals.
A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers.
Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency.
ROCHESTER, Minn. - Results of a Mayo Clinic survey published in the New England Journal of Medicine shows that while physicians are open to being involved in health care reform discussions, some opposition may exist.
GAINESVILLE, Fla. -- Scientists have discovered that even in adults born with extremely impaired sight, the brain can rewire itself to recognize sections of the retina that have been restored by gene therapy.
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.
A world-first study involving Monash University and the Cabrini Research Institute in Melbourne has revealed the injection of bone cement into broken vertebrae is not an effective treatment for patients suffering painful osteoporotic fractures.
WASHINGTON -- Though digital technologies and high-speed communications have significantly expanded the capabilities of scientists -- allowing them to analyze and share vast amounts of data -- these technologies are also raising difficult questions for researchers, institutions, and journals.
Researchers at the University of California, San Francisco Center for Excellence in Primary Care, as lead authors on commentaries in two of the nation's leading medical journals this week, call for a national effort to revive primary care as part of health care reform legislation.
BEER-SHEVA, ISRAEL, June 10, 2009 -- Metoclopramide, a drug approved in the U.S.
More than a decade after Harvard researchers first revealed that life and health insurance companies were major investors in tobacco stocks -- prompting calls upon them to divest -- the insurance industry has yet to kick the habit, they say.
[Mechelen Belgium, June 3, 2009] ?Interim results from an ongoing phase 2, randomized, placebo-controlled trial of the investigational drug TMC207 for the treatment of multidrug-resistant tuberculosis (MDR-TB) were published in the New England Journal of Medicine today. TMC207 is being developed by Tibotec BVBA.
NEW YORK (May 29, 2009) -- Patients who have gastroesophageal reflux disease (GERD) for a prolonged period have an increased risk of developing Barrett's esophagus, a pre-cancerous condition where the tissue lining the esophagus becomes damaged by stomach acid and transformed into something like the inside of the stomach.
ORLANDO, Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for those who are older, according to Mayo Clinic and Dana-Farber Cancer Institute scientists who will present their findings at the American Society of Clinical Oncology's (ASCO)
For the first time, a combination of aspirin and the anti-platelet drug dipyridamole has been shown to significantly reduce blockages and extend the useful life of new artery-vein access grafts used for hemodialysis, according to a study by the Dialysis Access Consortium (DAC).
